Roche's Oncology Drug Strategy Emphasizes Comprehensive Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Executives emphasized the role of "comprehensive diagnostics" in its plan to establish a dominant position in immuno-oncology drugs at this years' American Society of Clinical Oncology annual meeting.